Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(83)
•••
2O2Ovision
X
View Profile
View Bullboard History
Post by
2O2Ovision
on Jun 04, 2024 8:37am
New options
I've mostly stopped looking at this site but an amendment to the options plan has been filed with the SEC if anyone is interested. Cheers
(12)
•••
Quantum41
X
View Profile
View Bullboard History
Post by
Quantum41
on Jun 03, 2024 4:56pm
Asco 2024
Meeting Abstract: 2024 ASCO Annual Meeting I FREE ACCESS Developmental Therapeutics—Immunotherapy May 29, 2024 Share on
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 4:48pm
RE:RE:Big pharma is set to keep signing bigger deals in 2024
https://www.prnewswire.com/news-releases/beyond-borders-2024-innovative-biotech-industry-is-well-positioned-for-a-comeback-when-the-financing-environment-improves-says-ey-report-302159891.html
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 4:47pm
RE:Big pharma is set to keep signing bigger deals in 2024
June 03, 2024 - EY Beyond Borders - " In parallel, Big Pharma is in the midst of a US$350 billion patent cliff,1 driven by a loss of exclusivity for some of the best-selling biologic
...more
(1402)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Jun 03, 2024 2:01pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
https://www.fiercebiotech.com/biotech/pharma-awaits-fed-relief-1t-firepower-spend-biotech-innovation-report
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 10:58am
RE:RE:RE:RE:RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
Shouls read : " .. enabling the transformation of a "cold tumor" into a "hot tumor" and remodels the TME for the synergistic addition of immune checkpoint
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 10:45am
RE:RE:RE:RE:RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
Should read: " ONCY's pelareorep stimulates the immune system.through the enhancement of new and existing TiLs ..."
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 10:40am
RE:RE:RE:RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
Antibodies are responsible for tumor targeting, while agonists like ONCY's pelareorep stimulates the immune system through the enhance of new and existing TiLs, and activates innate and adaptive
...more
(55)
•••
spesestsemper
X
View Profile
View Bullboard History
Post by
spesestsemper
on Jun 03, 2024 10:36am
Biotech Advances in 2024: Innovative Treatments Aim to Boost
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates (newswire.ca) USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER,
...more
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 10:32am
RE:RE:RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
May 29, 2024 - " Chemotherapy drugs are well suited to killing cancer cells, but they’re bad at killing only cancer cells — the destruction of healthy tissue has been an inevitable outcome
...more
(93)
•••
CaseyL
X
View Profile
View Bullboard History
Comment by
CaseyL
on Jun 03, 2024 10:14am
RE:RE:RE:RE:RE:John Mark Lievonen
This is going to be a last minute success ONLY.
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 10:11am
RE:RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
https://www.nasdaq.com/press-release/emerging-trends-in-oncology:-asco-2024-highlights-next-gen-antibody-drug-conjugates
(5649)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Jun 03, 2024 10:03am
RE:RE:RE:RE:Resistance to ADCs in the treatment of solid tumors
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36068616
(486)
•••
Lesalpes29
X
View Profile
View Bullboard History
Comment by
Lesalpes29
on Jun 03, 2024 9:15am
RE:RE:RE:RE:John Mark Lievonen
Lol unstable with his 10B buyout is not really zen! Asco good or not, we will see. Trying to keep all my share during next month, not going to be easy! GO Oilers GO!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
The Convenience of Modern Banking With the Benefits of Bitcoin Has Arrived
Xcyte Digital Corp. Announces Execution of Definitive Agreement with MCON Live Inc.
AirBoss of America Corp. Class Action Certification and Settlement